Grasim's ₹17,200 cr renewables bet, Biocon's Mylan overhang

Grasim's ABRen renewables platform is buying Shell's Sprng Energy for ₹17,200 cr enterprise value, about 7.9% of Grasim's market cap. With 9.3 GWp, the deal vaults ABRen into India's top tier of clean energy players and materially reshapes the conglomerate's sum-of-parts story. The backing of Global Infrastructure Partners adds execution credibility. The open question is how Grasim funds this alongside its paints and textiles capex without stretching a balance sheet that already carries 1.88x debt/equity.

Mylan has sold its entire 5.64% Biocon stake worth ₹4,000 cr in open-market transactions. The exit ends a long-standing strategic partnership in biosimilars and leaves a supply overhang on a stock that trades at a trailing P/E of 175x with ROE of just 4.7%. For a large-cap pharma already navigating a 57% PAT decline, this adds a new layer of overhang and raises questions about the partnership's future.

Sigma Advanced Systems is buying UK aerospace precision engineering firm Bromford for ₹153 cr cash, adding 46% to its consolidated revenue. At ₹228 cr, Bromford's revenue is a step change for Sigma, deepening ties with leading aerospace OEMs. The cash spend is modest against a ₹10,840 cr market cap, making this a bolt-on that immediately boosts scale without stretching the balance sheet.

KEC International has won ₹1,180 cr in new orders including its first data centre project, opening a new end-market tied to India's digital infrastructure push. The haul, about 9% of market cap, adds to a busy quarter that already included ₹1,754 cr and ₹1,303 cr wins. For a mid-cap EPC with trailing revenue down 7%, this pipeline validates demand recovery across T&D, renewables and civil segments.

Apollo Micro Systems has bagged ₹189.57 cr in defence orders, adding to an order book that already drove 81% revenue growth. The diversified customer base reduces concentration risk, but with a P/E of 126x the stock already prices this in. Execution on delivery, not order wins, is the next test, especially after the company just announced a ₹3,322 cr preferential issue.

Raymond Realty has signed a ₹8,500 cr joint development agreement for its maiden South Mumbai project in Parel, nearly double its market cap. The asset-light JDA model limits capital risk while giving the small-cap developer a foothold in Mumbai's premium micro-market. This follows a 129% pre-sales surge in Q1, reinforcing strong demand and execution momentum.

AYE Finance is proposing a ₹4,000 cr NCD raise, almost the size of its entire market cap. For a small-cap NBFC with debt/equity of 2.73x, this would dramatically expand its balance sheet and signal aggressive growth. The cost of capital will be the key variable. The company's recent rating upgrade to IND A+ helps, but the next test is whether this funds profitable expansion or margin compression.

Capacit'e Infraprojects has secured a ₹482 cr repeat order for a Mumbai high-rise, equal to 18% of FY26 revenue. Combined with a ₹589 cr Raymond contract from June, the order book now offers 24-30 months of visibility. But the company recently cut its FY27 EBITDA margin guidance to 15.5-16.5%, making disciplined project execution the real test.

Dalmia Bharat Sugar is betting US$132 mn on a Tanzania sugar mill, with an equity commitment of US$22.7 mn, or 6.5% of its market cap. This signals a long-term strategic shift into East Africa for a small-cap sugar company with declining domestic revenue. The execution risk is high, but the diversification away from a cyclical Indian market is a calculated move.

International Conveyors' promoters have pledged 91% of their stake against a ₹498 cr group loan, which is 95% of the micro-cap's market cap. The security cover ratio of 0.66x means shares are already worth less than the debt, raising real invocation risk. This debt is for a group entity, not the listed company, making the stock a hostage to external repayment.

Rose Merc continues its aggressive fintech pivot, issuing ₹8.16 cr in preferential shares (18% of market cap) and lending ₹10 cr to its fintech arm. For a company with revenue down 63% and a market cap of just ₹41 cr, this is a bet-the-farm strategy. The combined funding and loan commitments dilute existing holders while the core trading business shrinks.

Vraj Iron & Steel is planning a ₹450 cr greenfield plant, exceeding its ₹391 cr market cap and shifting it from debt-free to leveraged. The location and incentives make strategic sense, but executing a 30-month capex cycle for a micro-cap with no prior project of this scale is a stretch. The next test is funding clarity and milestone progress.

Susan Electricals' Q1 revenue surged 254% to ₹95 cr, with an order book of ₹292 cr, well above its ₹452 cr market cap. The company says ₹142 cr of unexecuted orders will be delivered in the next 90 days, implying near-term revenue alone could exceed the current market value. For a micro-cap with a 38% ROE and clean balance sheet, the valuation disconnect is striking.

Amalgamated Electricity, a ₹28 cr shell with zero revenue, is proposing a ₹650 cr raise, 23x its market cap. The preferential issue and strategic pivot signal a blank-cheque entry into new-age sectors, with the allottees set to own virtually the entire company post-issue. For existing holders, dilution is total; the only value is in what the new investors build.